Skip to Content

Coronavirus information for Feinberg.

Download the full-sized PDF of Valproate/Lamotrigine and Growth Retardation
Download the file

Actions

Download Analytics Citations

Export to: EndNote

Collections

This file is in the following collections:

Pediatric Neurology Briefs: Volume 15, Issue 12

Valproate/Lamotrigine and Growth Retardation Open Access (recommended)

Descriptions

Resource type(s)
Article
Keyword
Valproate
Bone Mineral Density
Lamotrigine
Rights
Attribution 4.0 International

Creator
Millichap, J. Gordon
Abstract
Growth and bone metabolism were evaluated in 27 boys and 26 girls, aged 3 to 17 years (mean 9.2 yrs), with epilepsy treated with valproate (VPA) and/or lamotrigine (LTG) for >2 years, in a study at McMaster University and Childrens Hospital, Hamilton, Ontario, Canada.
Publisher
DigitalHub. Galter Health Sciences Library
Pediatric Neurology Briefs Publishers
Date Created
2001
Original Identifier
PNB-15-91-b
Language
English
Subject: MESH
Pediatrics
Neurology
Infant
Nervous System Diseases
Child Development
Neurosurgery
Child
Brain Diseases
DOI
10.15844/pedneurbriefs-15-12-4

File Details

File Properties
Mime type: application/pdf
File size: 719.2 kB